A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors

Clinical trial NCT04947033 · UNKNOWN

Trial details

NCT number: NCT04947033
Sponsor: I-Mab Biopharma US Limited
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-12-31
Primary completion: 2024-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.